| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $118,279 | 11 | 100 |
| Ophir Eran | President and CEO | 0 | $0 | 3 | $42,934 | $-42,934 |
| Levine Zurit | SVP, Business Development | 0 | $0 | 8 | $75,345 | $-75,345 |
Compugen Ltd., an Israeli-based company established in 1993 and headquartered in Holon, is a clinical-stage enterprise focused on the discovery, development, and commercialization of therapeutic and product candidates. Its operations extend across Israel, the United States, and Europe. The company’s core activities center around its immuno-oncology pipeline, which includes several investigational treatments: COM701, an anti-PVRIG antibody currently undergoing Phase I clinical studies for solid tumors. COM902, a therapeutic antibody designed to …
Over the last 12 months, insiders at Compugen Ltd. have bought $0 and sold $118,279 worth of Compugen Ltd. stock.
On average, over the past 5 years, insiders at Compugen Ltd. have bought $0 and sold $118,279 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
| 2026-07-09 | Sale | Levine Zurit | SVP, Business Development | 1,875 0.002% | $2.50 | $4,688 | -4.66% | |
| 2026-04-24 | Sale | Levine Zurit | SVP, Business Development | 2,000 0.0022% | $3.20 | $6,400 | -23.55% | |
| 2026-04-24 | Sale | Ophir Eran | President and CEO | 5,000 0.0055% | $3.20 | $16,001 | -23.55% | |
| 2026-04-14 | Sale | Levine Zurit | SVP, Business Development | 2,000 0.0024% | $2.80 | $5,600 | -17.36% | |
| 2026-04-14 | Sale | Ophir Eran | President and CEO | 5,000 0.0062% | $2.90 | $14,521 | -17.36% | |
| 2026-04-10 | Sale | Levine Zurit | SVP, Business Development | 3,125 0.0034% | $2.56 | $8,013 | -7.75% | |
| 2026-04-08 | Sale | Levine Zurit | SVP, Business Development | 5,375 0.0059% | $2.42 | $13,008 | +3.93% | |
| 2026-04-07 | Sale | Levine Zurit | SVP, Business Development | 2,500 0.0026% | $2.30 | $5,750 | +2.59% | |
| 2026-04-01 | Sale | Levine Zurit | SVP, Business Development | 3,500 0.0037% | $2.20 | $7,700 | +8.18% | |
| 2026-04-01 | Sale | Ophir Eran | President and CEO | 5,625 0.006% | $2.21 | $12,413 | +8.18% | |
| 2026-03-26 | Sale | Levine Zurit | SVP, Business Development | 11,875 0.0124% | $2.04 | $24,187 | +15.53% |
| Increased Positions | 23 | +26.14% | 2M | +16.57% |
| Decreased Positions | 28 | -31.82% | 2M | -15.51% |
| New Positions | 12 | New | 2M | New |
| Sold Out Positions | 11 | Sold Out | 1M | Sold Out |
| Total Postitions | 83 | -5.68% | 13M | +1.06% |